# AptarGroup, Inc. – Consensus ‘buy’ rating and 9.2% Upside Potential

- Link: https://www.directorstalkinterviews.com/aptargroup-inc.consensus-buy-rating-and-9.2-upside-potential/4121130170
- Published: 2023-10-20T14:09:44+01:00
- Author: Charlotte Edwards

**AptarGroup, Inc.** which can be found using ticker (ATR) now have 4 analysts in
total covering the stock. The consensus rating is pointing to ‘buy’. The target 
price High/Low ranges between 152 and 125 with the average target price sitting 
at $138.50. Given that the stocks previous close was at $126.78 this indicates there
is a potential upside of 9.2%. It’s also worth noting that there is a 50 day moving
average of $125.56 and the 200 day moving average is $118.47. The company has a 
market capitalization of 8.25B. The current share price for the company is: 125.73
USD

 The potential market cap would be $9,015,448,411 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 33.26, revenue per share of 51.83
and a 5.73% return on assets.

AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and 
consumer product dispensing, sealing and active packaging solutions and services.
The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar
Closures. Aptar Pharma includes operations that sells dispensing systems and sealing
solutions and also manufactures and sells elastomeric primary packaging components.
The Company’s products include stoppers for infusion, antibiotic, lyophilization
and diagnostic vials. The Aptar Beauty segment includes operations that sell dispensing
systems, drug delivery systems, sealing solutions and services to the prescription
drug, consumer health care, injectables, and active material science solutions markets.
The Aptar Closures business serves multiple markets, including food, beverage, personal
care, home care, beauty and healthcare. This segment offers food protection business
and elastomeric flow-control technology business.

Share on: